Navigation Links
Kevin Garrity Named President of HollisterStier Allergy

SPOKANE, Wash. April 26, 2011 /PRNewswire/ -- HollisterStier Allergy announced that they have recently added Kevin Garrity as the president of the business, illustrating the continued investment in the organization by their corporate parent, Jubilant Life Sciences, Ltd (Jubilant).  


Garrity holds over 25 years of healthcare experience, 15 of which involved selling in vitro allergy diagnostic products and services.  Garrity recently held the title of General Manager and Chief Operating Officer for an in vitro diagnostics manufacturer and clinical laboratory service provider dedicated to immune hypersensitivities.  Garrity holds a Bachelor of Science in medical technology and a Master of Business Administration from Texas State University.  

HollisterStier Allergy has recently seen an influx of investment from Jubilant, evidenced by the completion of recent laboratory and production area expansions, the undertaking of research and development projects, and the addition of Garrity to HollisterStier Allergy leadership.

About HollisterStier Allergy

HollisterStier Allergy is a leading manufacturer of high-quality allergy products for the global market.  The organization provides a complete line of products for the testing and treatment of allergies.  HollisterStier Allergy's product portfolio includes many exclusive products, such as the Acetone Precipitated (AP)™ line of extracts and a complete line of skin testing devices including QUINTIP® and ComforTen®.  HollisterStier Allergy is owned by Jubilant Life Sciences, Ltd., and is located in Spokane, Washington.

For more info:

About Jubilant

Jubilant Life Sciences Limited (formerly Jubilant Organosys Ltd) is an integrated Pharma and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution (DDDS) provider out of India. The Company provides Life Sciences products and services across the value chain. With 10 world-class manufacturing facilities and a team of ~5700 people across the globe, the Company is committed to deliver value to its customers spread across 60 countries. The Company is well recognized as a 'Partner of Choice' by leading life sciences companies worldwide.

For more info:

Alison Marlin

SOURCE HollisterStier Allergy
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Appoints Kevin Bracken Vice President of Manufacturing
2. Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
3. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
4. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
5. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
8. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
9. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
10. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
11. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second time in ... STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, ... , US2020’s mission is to change the trajectory of STEM education in America ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
(Date:10/9/2017)... SAN DIEGO , Oct. 9, 2017 /PRNewswire/ ... a biological mechanism by which its ProCell stem ... of critical limb ischemia.  The Company, demonstrated that ... the amount of limbs saved as compared to ... of the molecule HGF resulted in reduction of ...
Breaking Biology Technology:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):